Coagulopathy after traumatic brain injury. - Wikidata - awgldk - TriplyDB

Coagulopathy after traumatic brain injury.

Coagulopathy after traumatic brain injury.

http://www.wikidata.org/entity/Q37981549

about

Management of Deep Vein Thrombosis (DVT) Prophylaxis in Trauma Patients New Prognostic Biomarkers in Patients With Traumatic Brain Injury Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats.Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.Antiplatelet therapy: a double-edged sword in head injury?Impact of moderate blast exposures on thrombin biomarkers assessed by calibrated automated thrombography in rats.Increased Risk of Stroke in Patients of Concussion: A Nationwide Cohort Study Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options.Prevention of venous thrombotic events in brain injury: review of current practices.Coagulopathy associated with traumatic brain injury.Coagulopathy after severe pediatric trauma Where are we in the modelling of traumatic brain injury? Models complicated by secondary brain insults.Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: Definition, incidence and outcomes.Review of Thromboelastography in Neurocritical Care.Epidural Hematoma Treated Conservatively: When to Expect the Worst.Tripartite Stratification of the Glasgow Coma Scale in Children with Severe Traumatic Brain Injury and Mortality: An Analysis from a Multi-Center Comparative Effectiveness Study.Characterization of distinct coagulopathic phenotypes in injury: Pathway-specific drivers and implications for individualized treatment.Timing of fracture fixation from an Intensive Care Unit perspective: the obstacles to early fracture fixation.Progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage: characteristics, risk factors and impact on management.Response of the cerebral vasculature following traumatic brain injury.Side Effects of Indomethacin in Refractory Post-traumatic Intracranial Hypertension: A comprehensive case study and review Factors related to catheter-induced hemorrhage after brain parenchymal catheterization.What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention?Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury.Thromboelastography defines late hypercoagulability after TBI: a pilot study.External validation of the international mission for prognosis and analysis of clinical trials model and the role of markers of coagulation.Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury.Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy.Blood ethanol levels are not related to coagulation changes, as measured by thromboelastography, in traumatic brain injury patients.The Utility of Thromboelastography for Predicting The Risk of Progression of Intracranial Hemorrhage in Traumatic Brain Injury Patients.Microparticles impact coagulation after traumatic brain injury.Retrospective evaluation of the BIG score to predict mortality in pediatric blunt trauma.Thromboelastography After Murine TBI and Implications of Beta-Adrenergic Receptor Knockout.The coagulopathy of trauma.

P2860

Q26750920-FF552ECC-208B-4F62-92C3-A04996E5FD85 Q26768672-2BD132B6-69F3-4037-BB24-CB20BB1BA57F Q26995130-7D901857-38DB-4FF0-BE3C-DAC37BFF471D Q30352890-E658ECD8-0331-46BC-B677-EC202D54151E Q33786832-7BB50DCA-CBBF-447F-8B35-DBB9DDF8FD59 Q35146718-09EA07E3-DF23-49B9-B540-6E21A4E8BF74 Q36902530-072CEE1D-97A2-4BAA-A443-8961C47CED23 Q37272702-A1EB9882-2D22-4DA0-9D84-B1AEB529391D Q37724445-E34E1D3E-879C-4E41-BD04-CAB7BDA909C6 Q37731832-064093BE-0A5E-4C82-9029-DB3B721EEDEF Q38072761-F8170921-7876-4F1B-BC03-2F71157A2602 Q38126028-B7B61EFD-434F-434C-A194-DF6D91E97FB7 Q38138903-6C6E9FD9-3A5F-4DC8-89E6-192FE8666296 Q38191128-351B06D3-C9E8-4669-81A8-8456A5BDC8E1 Q38238825-2A93BC8D-77EE-460F-9A86-3BF1F6022820 Q38242952-A1A791D8-B159-418C-A87C-170E869CD2AF Q38567028-3916D333-1BF7-4F11-ACCB-69F70569A049 Q38703268-89FCB6CC-1E78-4606-B93D-CC7EA70E80AB Q38774838-C15C6CE4-43CC-4E6C-8E4F-B5C61E3CA041 Q38879831-AD5F10C4-AAAA-44B9-82EE-9AD07058A95C Q38978286-0FE2BA86-792C-4D89-9684-93185D3EBA8C Q39109184-7773BA3E-E1A8-4D0B-8952-9292A10616B5 Q39221209-7FE3DF19-A10F-4253-9857-E42574156B0E Q41288406-E67567B8-A3D9-4DD5-9803-7D48A3E6561F Q41851466-826DD71D-2E29-4219-8060-F610741B378E Q42777722-6099B58A-2610-4340-89D8-94734FF4B5F8 Q42908897-5BE3ADCE-9E12-4121-BB0A-C3FCA604458C Q43723087-F81DE32C-5536-4D95-B2F4-3F520841EB31 Q44633047-7D8B9917-0F34-4CC8-841A-BC87F1A23892 Q47179267-D02895AF-92D3-4CBE-9DB2-D031025DDC37 Q47322914-4AF1F812-E6EA-48BB-9BE1-2FB65C5C18A4 Q47866858-A211DC21-63D0-49D8-A518-25C35E703B37 Q48116820-2D524174-93BB-4812-858C-49F3D30D3D6E Q48244928-11E6D072-002E-4D18-9CA9-76B5677CA023 Q48605563-B6E7A92C-69D2-4EA4-A627-B77CCECD3BAC Q49151889-900F492A-1F68-4B74-B677-1DCBED11D4C5 Q53060218-7870B54B-08B2-4020-B51E-121D40954FEA

P2860

Coagulopathy after traumatic brain injury.

http://www.wikidata.org/entity/Q37981549

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Coagulopathy after traumatic brain injury.

@en

Coagulopathy after traumatic brain injury.

@nl

type

label

Coagulopathy after traumatic brain injury.

@en

Coagulopathy after traumatic brain injury.

@nl

prefLabel

Coagulopathy after traumatic brain injury.

@en

Coagulopathy after traumatic brain injury.

@nl

P1433

Q37981549-038100D6-68CD-4B70-95AE-3E13C0FECB5B

P1476

Q37981549-9FED455F-8324-4DF5-A0C8-CFCC637175CF

P2093

Q37981549-163E3BC6-92AC-4FF5-859E-532E0AF9C287

Q37981549-5D8C0EAB-19C1-440F-8784-8D63B15D77D0

Q37981549-74966989-AE9D-45DF-ADAB-A5B5036099E2

Q37981549-8CAB62AE-1B94-4420-8D4C-25E112DB4658

Q37981549-EFC69A24-3451-4C0B-BA0E-B1E8680C3F77

P2860

Q37981549-0C2677B3-EFA3-4670-95E7-2475958D26C0

Q37981549-0D64B915-BF65-4ADE-ABE4-F94DFF875E9C

Q37981549-13DCCE4D-0084-4403-8775-D6CDAB000C99

Q37981549-1D280312-A13C-4FBB-BF83-EE0FB604E7AD

Q37981549-20906A2C-2981-4F7E-8AB5-92491EC76DA4

Q37981549-20BBAFCA-7A9E-4175-9564-F29B88361F1E

Q37981549-23EB033E-2EA2-49C5-8FE0-602F7630E016

Q37981549-2D4D9598-C767-4386-B82F-300D992AE272

Q37981549-2E887AE3-6F74-4622-96E3-7E6B59C53780

Q37981549-348BCF64-A896-499B-A965-55666D9238F3

P304

Q37981549-4D9D3F51-DF7C-44A2-9D5B-056A88DFE9AC

P31

Q37981549-17FCBD0D-11FB-447A-8FA7-5D40198D9A43

P356

Q37981549-479E1CE2-FC2D-4D89-A4CC-50D7E96ED51A

P407

Q37981549-4A810580-728E-44CE-A081-B63A72C450A1

P433

Q37981549-379CF678-860F-46F6-8207-B4651828673E

P478

Q37981549-32C4929F-84BD-4201-8EEA-F1C936F9CDA2

P577

Q37981549-D9278E7F-760A-4BA7-A8BF-D90D8BA36833

P698

Q37981549-2645AF7C-7F7B-40CB-AB09-A63B7DD29D8B

P921

Q37981549-6556C8BF-C9D1-48CF-B7CB-60D03A0E9E0D

P356

NEU.0B013E31824D179B

P1433

P1476

Coagulopathy after traumatic brain injury.

@en

P2093

Geoffrey T Manley

http://www.w3.org/2001/XMLSchema#string

Mathieu Laroche

http://www.w3.org/2001/XMLSchema#string

Matthew E Kutcher

http://www.w3.org/2001/XMLSchema#string

Michael C Huang

http://www.w3.org/2001/XMLSchema#string

Mitchell Jay Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

The risk associated with aprotinin in cardiac surgery

Antithrombin treatment in patients with traumatic brain injury: a pilot study.

Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration.

Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers.

Platelet dysfunction in patients with severe traumatic brain injury.

Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.

Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged.

Time course of coagulopathy in isolated severe traumatic brain injury.

Defibrination after brain-tissue destruction: A serious complication of head injury.

P304

1334-1345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1227/NEU.0B013E31824D179B

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22307074

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury